The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Prevalence of Duchenne and Becker Muscular Dystrophies in the United States
Open accessAbstract
OBJECTIVE: To estimate prevalence of childhood-onset Duchenne and Becker muscular dystrophies (DBMD) in 6 sites in the United States by race/ethnicity and phenotype (Duchenne muscular dystrophy [DMD] or Becker muscular dystrophy [BMD]). METHODS: In 2002, the Centers for Disease Control and Prevention established the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet) to conduct longitudinal, population-based surveillance and research of DBMD in the United States. Six sites conducted active, multiple-source case finding and record abstraction to identify MD STARnet cases born January 1982 to December 2011. We used cross-sectional analyses to estimate prevalence of DBMD per 10 000 boys, ages 5 to 9 years, for 4 quinquennia (1991–1995, 1996–2000, 2001–2005, and 2006–2010) and prevalence per 10 000 male individuals, ages 5 to 24 years, in 2010. Prevalence was also estimated by race/ethnicity and phenotype. RESULTS: Overall, 649 cases resided in an MD STARnet site during ≥1 quinquennia. Prevalence estimates per 10 000 boys, ages 5 to 9 years, were 1.93, 2.05, 2.04, and 1.51, respectively, for 1991–1995, 1996–2000, 2001–2005, and 2006–2010. Prevalence tended to be higher for Hispanic individuals than non-Hispanic white or black individuals, and higher for DMD than BMD. In 2010, prevalence of DBMD was 1.38 per 10 000 male individuals, ages 5 to 24 years. CONCLUSIONS: We present population-based prevalence estimates for DBMD in 6 US sites. Prevalence differed by race/ethnicity, suggesting potential cultural and socioeconomic influences in the diagnosis of DBMD. Prevalence also was higher for DMD than BMD. Continued longitudinal surveillance will permit us to examine racial/ethnic and socioeconomic differences in treatment and outcomes for MD STARnet cases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of Muscular Dystrophies: A Systematic Literature Review
Theadom, A., Rodrigues, M., Roxburgh, R., Balalla, S., Higgins, C., Bhattacharjee, R., Jones, K., Krishnamurthi, R., & Feigin, V. (2014) · Neuroepidemiology · doi:10.1159/000369343 · Cited by 2,046
Eagle, M., Baudouin, S. V., Chandler, C., Giddings, D. R., Bullock, R., & Bushby, K. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(02)00140-2 · Cited by 1,009
Norwood, F. L. M., Harling, C., Chinnery, P. F., Eagle, M., Bushby, K., & Straub, V. (2009) · Brain · doi:10.1093/brain/awp236 · Cited by 541
Glucocorticoid corticosteroids for Duchenne muscular dystrophy
Manzur, A., Kuntzer, T., Pike, M., & Swan, A. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003725.pub2 · Cited by 539
A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy
Mah, J. K., Korngut, L., Dykeman, J., Day, L., Pringsheim, T., & Jette, N. (2014) · Neuromuscular Disorders · doi:10.1016/j.nmd.2014.03.008 · Cited by 490
Glucocorticoid corticosteroids for Duchenne muscular dystrophy
Manzur, A. Y., Kuntzer, T., Pike, M., & Swan, A. V. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003725.pub3 · Cited by 437
Eagle, M., Bourke, J., Bullock, R., Gibson, M., Mehta, J., Giddings, D., Straub, V., & Bushby, K. (2007) · Neuromuscular Disorders · doi:10.1016/j.nmd.2007.03.002 · Cited by 341
Ciafaloni, E., Fox, D. J., Pandya, S., Westfield, C. P., Puzhankara, S., Romitti, P. A., Mathews, K. D., Miller, T. M., Matthews, D. J., Miller, L. A., et al. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.02.007 · Cited by 245
Self-citationNeuromuscular disorders in childhood: a descriptive epidemiological study from western Sweden
Darin, N., & Tulinius, M. (2000) · Neuromuscular Disorders · doi:10.1016/s0960-8966(99)00055-3 · Cited by 205
Jeppesen, J., Green, A., Steffensen, B. F., & Rahbek, J. (2003) · Neuromuscular Disorders · doi:10.1016/s0960-8966(03)00162-7 · Cited by 192
Formal genetics of muscular dystrophy.
Morton, N. E., & Chung, C. S. (1959) · PubMed · Cited by 186
Epidemiology of Neuromuscular Diseases, Including the Postpolio Sequelae, in a Swedish County
Ahlström, G., Gunnarsson, L., Leissner, P., & Sjödén, P. (1993) · Neuroepidemiology · doi:10.1159/000110327 · Cited by 105
The prevalence of inherited neuromuscular disease in Northern Ireland
Hughes, M. I., Hicks, E. M., Nevin, N. C., & Patterson, V. (1996) · Neuromuscular Disorders · doi:10.1016/0960-8966(94)00017-4 · Cited by 95
Duchenne Muscular Dystrophy: A 30-Year Population-Based Incidence Study
Dooley, J. M., Gordon, K., Dodds, L. A., & MacSween, J. (2010) · Clinical Pediatrics · doi:10.1177/0009922809347777 · Cited by 91
den Enden, A. T. J. M. H.-V., Madan, K., Breuning, M. H., et al. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.101 · Cited by 74
Birth and population prevalence of Duchenne muscular dystrophy in the Netherlands
van Essen, A. J., Busch, H. F. M., Meerman, G. J. T., et al. (1992) · Human Genetics · doi:10.1007/bf00197256 · Cited by 67
Prevalence of Neuromuscular Diseases in Chinese Children: A Study in Southern China
Chung, B. H., Wong, V. C. N., & Ip, P. (2003) · Journal of Child Neurology · doi:10.1177/08830738030180030201 · Cited by 58
Epidemiology of neuromuscular disorders in the under-20 population in Bologna province, Italy
Merlini, L., Stagni, S., Marri, E., & Granata, C. (1992) · Neuromuscular Disorders · doi:10.1016/0960-8966(92)90006-r · Cited by 52
A genetic study of Duchenne muscular dystrophy in West Midlands.
Bundey, S. (1981) · Journal of Medical Genetics · doi:10.1136/jmg.18.1.1 · Cited by 20
Topical Review: Dystrophinopathies: Clarification and Complication
Samaha, F. J., & Quinlan, J. G. (1996) · Journal of Child Neurology · doi:10.1177/088307389601100103 · Cited by 18
Kvasnicova, M., Styková, J., & Hudec, P. (1994) · PubMed · Cited by 7
Reproductive patterns among mothers of males diagnosed with Duchenne or Becker muscular dystrophy
Nabukera, S. K., Romitti, P. A., Caspers, K. M., et al. (2012) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35682 · Cited by 6
Self-citation
Cited by
Splice-switching antisense oligonucleotides as therapeutic drugs
Havens, M. A., & Hastings, M. L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw533 · Cited by 538
The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review
Ryder, S., Leadley, R. M., Armstrong, N., Westwood, M., de Kock, S., Butt, T., Jain, M., & Kleijnen, J. (2017) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-017-0631-3 · Cited by 530
Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis
Crisafulli, S., Sultana, J., Fontana, A., Salvo, F., Messina, S., & Trifirò, G. (2020) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-01430-8 · Cited by 500
Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy
Amoasii, L., Long, C., Li, H., Mireault, A. A., Shelton, J. M., Sanchez-Ortiz, E., McAnally, J. R., Bhattacharyya, S., Schmidt, F., Grimm, D., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan8081 · Cited by 247
Nguyen, T. N. T., Sha, S., Hong, M. S., Maloney, A. J., Barone, P. W., Neufeld, C., Wolfrum, J., Springs, S. L., Sinskey, A. J., & Braatz, R. D. (2021) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2021.04.006 · Cited by 107
Metadata
- Authors
- Romitti, P. A., Zhu, Y., Puzhankara, S., James, K. A., Nabukera, S. K., Zamba, G. K. D., Ciafaloni, E., Cunniff, C., Druschel, C. M., Mathews, K. D., Matthews, D. J., Meaney, F. J., Andrews, J. G., Conway, K. M. C., Fox, D. J., Street, N., Adams, M. M., & Bolen, J.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2015-03-01
- Volume
- 135
- Issue
- 3
- Pages
- 513-521
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2112513520
- Cited by
- 290
- References
- 22
- FWCI
- 7.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.